Seagen Inc.
Methods of inhibition of protein fucosylation in vivo using fucose analogs

Last updated:

Abstract:

The invention provides methods and compositions for the inhibition of fucosylation of proteins, including antibodies, in vivo by administration of a fucose analog.

Status:
Grant
Type:

Utility

Filling date:

25 Jun 2019

Issue date:

15 Jun 2021